| abstract |
The invention relates to the use of 1 H -imidazo[4,5- c ]quinolinone compounds and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1 H -imidazo[4,5- c ]quinolinone compounds for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1 H -imidazo[4,5- c ]quinolinone compounds to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1 H -imidazo[4,5- c ]quinolinone compounds, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1 H -imidazo[4,5- c ]quinolinone compounds; and a process for the preparation of the novel 1 H -imidazo[4,5- c ]quinolinone compounds. |